Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma

(2010) John D. Hainsworth et al.   CANCER

Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis

(2010) S. Mocellin et al.   JNCI-Journal of the National Cancer Institute

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-α2a as first line treatment in metastatic melanoma

(2010) Pia P. Vihinen et al.   MELANOMA RESEARCH

Acral Lentiginous Melanoma

(2009) Porcia T. Bradford et al.   ARCHIVES OF DERMATOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

(2009) Axel Hauschild et al.   JOURNAL OF CLINICAL ONCOLOGY

Melanoma Arising in African-, Asian-, Latino- and Native-American Populations

(2009) Brenda A. Shoo et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

(2008) Kazuyuki Ishihara et al.   International Journal of Clinical Oncology